Gene expression profiles of human breast cancer progression
Top Cited Papers
- 24 April 2003
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (10) , 5974-5979
- https://doi.org/10.1073/pnas.0931261100
Abstract
Although distinct pathological stages of breast cancer have been described, the molecular differences among these stages are largely unknown. Here, through the combined use of laser capture microdissection and DNA microarrays, we have generated in situ gene expression profiles of the premalignant, preinvasive, and invasive stages of human breast cancer. Our data reveal extensive similarities at the transcriptome level among the distinct stages of progression and suggest that gene expression alterations conferring the potential for invasive growth are already present in the preinvasive stages. In contrast to tumor stage, different tumor grades are associated with distinct gene expression signatures. Furthermore, a subset of genes associated with high tumor grade is quantitatively correlated with the transition from preinvasive to invasive growth.Keywords
This publication has 23 references indexed in Scilit:
- Breast ductal carcinoma in situ with microinvasionCancer, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Tumour markers in breast carcinoma correlate with grade rather than with invasivenessBritish Journal of Cancer, 2001
- Expression Profiling of Ductal Carcinoma in Situ by Laser Capture Microdissection and High-Density Oligonucleotide ArraysThe American Journal of Pathology, 2001
- Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow CytometryAmerican Journal of Clinical Oncology, 2001
- Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist AgreementLaboratory Investigation, 2000
- The Hallmarks of CancerCell, 2000
- Loss of Heterozygosity in Normal Tissue Adjacent to Breast CarcinomasScience, 1996
- Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potentialProceedings of the National Academy of Sciences, 1996
- R: A Language for Data Analysis and GraphicsJournal of Computational and Graphical Statistics, 1996